Page 73 - Read Online
P. 73

Page 20 of 23                                              Poznyak et al. Microbiome Res Rep. 2026;5:3





               121. Anand N, Gorantla VR, Chidambaram SB. The role of gut dysbiosis in the pathophysiology of neuropsychiatric disorders. Cells.
                  2022;12:54. DOI PubMed PMC
               122. Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:135. DOI PubMed PMC
               123. Sanchez P, Letarouilly JG, Nguyen Y, et al. Efficacy of probiotics in rheumatoid arthritis and spondyloarthritis: a systematic review and
                  meta-analysis of randomized controlled trials. Nutrients. 2022;14:354. DOI PubMed PMC
               124. Kazemi A, Soltani S, Ghorabi S, et al. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease
                  status: a systematic review and meta-analysis of clinical trials. Clin Nutr. 2020;39:789-819. DOI
               125. Li W, Zhang Y, Guo D, Gong R, Yuan J, Yang H. Quality of evidence supporting the role of probiotics for rheumatoid arthritis: an
                  overview of systematic reviews. Front Immunol. 2024;15:1397716. DOI PubMed PMC
               126. Feng J, Pan C, Gou Y, et al. EAT-lancet diet modifies the risk of rheumatoid arthritis through metabolomic signature. Arthritis
                  Rheumatol. 2026;78:68-79. DOI PubMed
               127. Zhang W, Mackay CR, Gershwin ME. Immunomodulatory effects of microbiota-derived short-chain fatty acids in autoimmune liver
                  diseases. J Immunol. 2023;210:1629-39. DOI PubMed PMC
               128. Liu XF, Shao JH, Liao YT, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023;14:1186892. DOI
                  PubMed PMC
               129. Schlatterer K, Peschel A, Kretschmer D. Short-chain fatty acid and FFAR2 activation - a new option for treating infections? Front Cell
                  Infect Microbiol 2021;11:785833. DOI PubMed PMC
               130. Chun E, Lavoie S, Fonseca-Pereira D, et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut
                  immunity. Immunity. 2019;51:871-884.e6. DOI PubMed PMC
               131. Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic
                  health. Gut Microbes. 2021;13:1-24. DOI PubMed PMC
               132. Fusco W, Lorenzo MB, Cintoni M, et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota.
                  Nutrients. 2023;15:2211. DOI PubMed PMC
               133. Tomé-Carneiro J, Visioli F. Plant-based diets reduce blood pressure: a systematic review of recent evidence. Curr Hypertens Rep.
                  2023;25:127-50. DOI PubMed PMC
               134. Baroni L, Rizzo G, Galchenko AV, Zavoli M, Serventi L, Battino M. Health benefits of vegetarian diets: an insight into the main topics.
                  Foods. 2024;13:2398. DOI PubMed PMC
               135. Pohl A, Schünemann F, Bersiner K, Gehlert S. The impact of vegan and vegetarian diets on physical performance and molecular
                  signaling in skeletal muscle. Nutrients. 2021;13:3884. DOI PubMed PMC
               136. Direito R, Rocha J, Sepodes B, Eduardo-Figueira M. Phenolic compounds impact on rheumatoid arthritis, inflammatory bowel disease
                  and microbiota modulation. Pharmaceutics. 2021;13:145. DOI PubMed PMC
               137. Gál R, Halmosi R, Gallyas F Jr, et al. Resveratrol and beyond: the effect of natural polyphenols on the cardiovascular system: a narrative
                  review. Biomedicines. 2023;11:2888. DOI PubMed PMC
               138. Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L. Quercetin, epigallocatechin gallate, curcumin, and resveratrol:
                  from dietary sources to human microrna modulation. Molecules. 2019;25:63. DOI PubMed PMC
               139. Meyer C, Brockmueller A, Ruiz de Porras V, Shakibaei M. Microbiota and resveratrol: how are they linked to osteoporosis? Cells
                  2024;13:1145. DOI PubMed PMC
               140. Wang Y, Hong C, Wu Z, et al. Resveratrol in intestinal health and disease: focusing on intestinal barrier. Front Nutr. 2022;9:848400.
                  DOI PubMed PMC
               141. Lefferts AR, Norman E, Claypool DJ, Kantheti U, Kuhn KA. Cytokine competent gut-joint migratory T cells contribute to inflammation
                  in the joint. Front Immunol. 2022;13:932393. DOI PubMed PMC
               142. Bono MR, Tejon G, Flores-Santibañez F, Fernandez D, Rosemblatt M, Sauma D. retinoic acid as a modulator of T cell immunity.
                  Nutrients. 2016;8:349. DOI PubMed PMC
               143. Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and role of regulatory T cells in rheumatoid arthritis. Front Immunol.
                  2021;12:626193. DOI PubMed PMC
               144. Sun H, Kuk W, Rivera-Nieves J, Lopez-Ramirez MA, Eckmann L, Ginsberg MH. β7 Integrin inhibition can increase intestinal
                  inflammation by impairing homing of CD25  FoxP3  regulatory T cells. Cell Mol Gastroenterol Hepatol. 2020;9:369-85. DOI PubMed
                                               hi
                                                     +
                  PMC
               145. Rossi B, Dusi S, Angelini G, et al. Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during
                  experimental autoimmune encephalomyelitis. Front Immunol. 2023;14:1071553. DOI PubMed PMC
               146. Song B, Guo W, He Y, Yao X, Sun J, Wang S. Targeting immune cell migration as therapy for inflammatory disease: a review. Front
                  Immunol. 2025;16:1650760. DOI PubMed PMC
   68   69   70   71   72   73   74   75   76   77   78